BiomX Inc 2026年季度报告

FORM 10-Q (Mark One)☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2026 Commission file number: 001-38762 Name of each exchange on whichregistered Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2) has been subject to such filing requirements for the past 90 days. Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files). Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smallerreporting company” and “emerging growth company” in Rule12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ The number of shares outstanding of the Registrant’s shares of Common Stock as of May 20, 2026 was 10,146,516. BIOMX, INC. Form 10-Q March 31, 2026 Page PART I — FINANCIAL INFORMATIONItem 1 – Unaudited Condensed Consolidated Financial StatementsCondensed Consolidated Balance Sheets – March 31,2026 (unaudited) and December 31, 2025F-1Condensed Consolidated Statements of Operations for the three months ended March 31, 2026 and 2025 (unaudited)F-2Condensed Consolidated Statement of Changes in Stockholders’ Equity (deficit) for the three months ended March 31,2026 and 2025 (unaudited)F-3Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2026 and 2025(unaudited)F-4Notes to Unaudited Condensed Consolidated Financial StatementsF-5-F-21Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations2Item 3 – Quantitative and Qualitative Disclosures About Market Risk11Item 4 – Controls and Procedures11PART II — OTHER INFORMATION12Item 1 – Legal Proceedings12Item 1A – Risk Factors12Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds12Item 3 – Defaults upon Senior Securities12Item 4 – Mine Safety Disclosures12Item 5 – Other Information12Item 6 – Exhibits12Exhibit IndexSIGNATURES13 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION This Quarterly Report on Form 10-Q (the “Quarterly Report”) includes “forward-looking statements” within the meaning ofthe Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”),and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The statements contained herein that arenot purely historical are forward-looking statements. Forward-looking statements include statements about our expectations, beliefs,plans, objectives, intentions, assumptions and other statements that are not historical facts. Words or phrases such as “anticipate,”“believe,” “continue,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “will” or similarwords or phrases, or the negatives of those words or phrases, may identify forward-looking statements, but the absence of these wordsdoes not necessarily mean that a statement is not forward-looking. For example, we are making forward-looking statements when wediscuss our business strategy and plans, including our strategic transition to defense, security, and critical infrastructure technologymarkets; the operations and integration of our recently acquired subsidiaries Dr. Frucht Systems Ltd. (“DFSL”) and Zorro Net Ltd.(“Zorronet”) and our wholly-owned subsidiary X Security & Defense LTD (“X Security”); our plan to regain compliance with thecontinued listing requirements of the NYSE American; our ability to raise additional capital and the sources of our liquidity; the futurebusiness prospects of our new operating subsidiaries; anticipated revenue from defense, security and critical-infrastructure customerengagements; and our ability to continue as a going concern. However, you should understand that these statements are not guaranteesof performance or results, and there are a number of risks, uncertainties and other important factors that could cause our actual resultsto differ materially from those expressed in the forward-looking statements, including